Clinical Trials

Our clinic trial news comes directly from the U.S. National Institutes of Health.   If you have additional trial information please post it to our website or let us know by email.

Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Cancer

Conditions:   Leukemia;   Lymphoma;   Multiple Myeloma;   Plasma Cell Neoplasm;   Myelodysplastic Syndromes;   Myeloproliferative Neoplasms
Interventions:   Biological: anti-thymocyte globulin;   Biological: G-CSF;   Drug: busulfan;   Drug: fludarabine phosphate;   Drug: methotrexate;   Drug: mycophenolate mofetil;   Drug: tacrolimus;   Procedure: allogeneic cell transplantation;   Drug: allopurinol
Sponsors:   Alliance for Clinical Trials in Oncology;   National Cancer Institute (NCI)
Completed - verified June 2016

Comparing Therapies for the Treatment of Severe Aplastic Anemia

Conditions:   Aplastic Anemia;   Hematologic Disease
Interventions:   Drug: Antithymocyte globulin & Cyclosporin A;   Drug: Cyclophosphamide & Cyclosporin A
Sponsor:   National Heart, Lung, and Blood Institute (NHLBI)
Completed - verified October 11, 2016

Combination Chemotherapy and Donor Stem Cell Transplant in Treating Patients With Aplastic Anemia or Hematologic Cancer

Conditions:   Chronic Myeloproliferative Disorders;   Leukemia;   Lymphoma;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Diseases;   Nonmalignant Neoplasm;   Unspecified Adult Solid Tumor, Protocol Specific;   Unspecified Childhood Solid Tumor, Protocol Specific
Interventions:   Biological: anti-thymocyte globulin;   Drug: busulfan;   Drug: carboplatin;   Drug: cyclophosphamide;   Drug: etoposide;   Drug: fludarabine phosphate;   Drug: melphalan;   Drug: thiotepa;   Radiation: total-body irradiation

Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer

Conditions:   Graft Versus Host Disease;   Leukemia;   Lymphoma;   Multiple Myeloma and Plasma Cell Neoplasm;   Myelodysplastic Syndromes
Interventions:   Biological: anti-thymocyte globulin;   Biological: filgrastim;   Drug: busulfan;   Drug: cyclophosphamide;   Drug: cyclosporine;   Drug: methylprednisolone;   Procedure: bone marrow ablation with stem cell support;   Procedure: umbilical cord blood transplantation;   Radiation: radiation therapy
Sponsor:   Roswell Park Cancer Institute
Active, not recruiting - verified June 2016

Pages